Literature DB >> 32516848

Effects of Porphyromonas gingivalis and Fusobacterium nucleatum on inflammasomes and their regulators in H400 cells.

Kübra Aral1,2, Michael R Milward3, Dhanak Gupta1, Paul R Cooper3,4.   

Abstract

INTRODUCTION: Inflammasomes are multiprotein complexes that regulate immune processes in response to infections and tissue damage. They modulate Interleukin-1beta (IL-1β) expression, a major proinflammatory cytokine. The inflammasome/IL-1β pathway is involved in head and neck squamous cell carcinoma (HNSCC) progression and the periodontal pathogens Fusobacterium nucleatum (Fn) and Porphyromonas gingivalis (Pg) have been reported to cause chronic inflammation in HNSCC. The aim of this study was to characterise the role of these pathogens in regulating inflammasome activity and the IL-1β response in HNSCC in vitro.
METHODS: An HNSCC cell line (H400) was exposed to Fn and Pg individually or in combination for 24h, ± incubation for 30 min with 5 mM adenosine triphosphate (ATP). Transcript levels of inflammasomes, NLRP3 and AIM2; inflammasome-regulatory proteins, POP1, CARD16 and TRIM16; and inflammasome-component, ASC and caspase 1 and IL-1β, were assayed by RT-PCR. Expression of IL-1β was by immunocytochemistry and ELISA.
RESULTS: NLRP3 expression was significantly upregulated in response to Pg, Fn + Pg, Pg + ATP and Fn + Pg + ATP. AIM2 was significantly upregulated by Fn, Pg and Fn + Pg + ATP exposure. All conditions significantly upregulated IL-1β gene expression. POP1 expression was significantly downregulated by Pg or Fn exposure but not by Fn + Pg. Intracellular pro- and mature IL-1β were significantly higher following Fn and Pg + ATP exposure.
CONCLUSION: Pg alone increased IL-1β by upregulating AIM2, NLRP3 and downregulating POP1. Fn promoted IL-1β by increasing AIM2 and downregulating POP1. Pg + ATP with or without Fn upregulated NLRP3, IL-1β by downregulating POP1. Periodontal pathogens may contribute to HNSCC pathogenesis by increasing the IL-1β response due to inflammasome dysregulation.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Fusobacterium nucleatumzzm321990; zzm321990Porphyromonas gingivaliszzm321990; head and neck cancer; inflammasome; interleukin-1 beta

Year:  2020        PMID: 32516848     DOI: 10.1111/omi.12302

Source DB:  PubMed          Journal:  Mol Oral Microbiol        ISSN: 2041-1006            Impact factor:   3.563


  6 in total

Review 1.  TRIMs: Generalists Regulating the NLRP3 Inflammasome Signaling Pathway.

Authors:  Nian-Hua Deng; Zhi-Xiang Zhou; Hui-Ting Liu; Zhen Tian; Ze-Fan Wu; Xi-Yan Liu; Wen-Hao Xiong; Zuo Wang; Zhi-Sheng Jiang
Journal:  DNA Cell Biol       Date:  2022-02-18       Impact factor: 3.311

2.  Alveolar Bone Loss, Tooth Loss and Oral Cancer Mortality in Older Patients: A Retrospective Cohort Study.

Authors:  Yifeng Qian; Huiting Yu; Weijun Yuan; Jiaqing Wu; Qingyu Xu; Nianrou Mei; Xudong Wang; Chunfang Wang
Journal:  Clin Interv Aging       Date:  2020-08-18       Impact factor: 4.458

Review 3.  The cancer metabolic reprogramming and immune response.

Authors:  Longzheng Xia; Linda Oyang; Jinguan Lin; Shiming Tan; Yaqian Han; Nayiyuan Wu; Pin Yi; Lu Tang; Qing Pan; Shan Rao; Jiaxin Liang; Yanyan Tang; Min Su; Xia Luo; Yiqing Yang; Yingrui Shi; Hui Wang; Yujuan Zhou; Qianjin Liao
Journal:  Mol Cancer       Date:  2021-02-05       Impact factor: 27.401

Review 4.  More Than Just a Periodontal Pathogen -the Research Progress on Fusobacterium nucleatum.

Authors:  Yuanxin Chen; Zhijie Huang; Zhengming Tang; Yisheng Huang; Mingshu Huang; Hongyu Liu; Dirk Ziebolz; Gerhard Schmalz; Bo Jia; Jianjiang Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-02-03       Impact factor: 5.293

Review 5.  Fusobacterium nucleatum and Malignant Tumors of the Digestive Tract: A Mechanistic Overview.

Authors:  Yue Lai; Jun Mi; Qiang Feng
Journal:  Bioengineering (Basel)       Date:  2022-06-28

Review 6.  Involvement of Fusobacterium Species in Oral Cancer Progression: A Literature Review Including Other Types of Cancer.

Authors:  Natsumi Fujiwara; Naoya Kitamura; Kaya Yoshida; Tetsuya Yamamoto; Kazumi Ozaki; Yasusei Kudo
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.